Unlike routine endoscopic procedures, endoscopic retrograde cholangiopancreatography (ERCP) combines several unique challenges. Despite defined indications, the complexity and length of each procedure are often difficult to predict because of unforeseen challenges with cannulation and subsequent therapy. Patients are usually in…
An increasing amount of evidence suggests that Food and Drug Administration (FDA)–recommended measures for duodenoscope reprocessing are insufficient to guarantee against transmission of infection. As a result, improved techniques for endoscope reprocessing have attracted interest from many research groups. Reported…
Endoscopic retrograde cholangiopancreatography (ERCP) has become the preferred technique for the management of patients with a variety of benign and malignant pancreaticobiliary disorders. Procedural success and safety depend to a large extent on proper patient selection for the appropriate indication,…
The scope and practice of endoscopic retrograde cholangiopancreatography (ERCP) has evolved over the past 2 decades. First, with the advances in magnetic resonance cholangiopancreatography (MRCP; see Chapter 34 ) in both academic and private settings alike, nearly all ERCP is…
The ERCP room can range from very basic to state-of-the-art. Whereas smaller institutions with low ERCP volumes often perform ERCP in the radiology department or operating room, most centers with a larger ERCP volumes perform ERCP in dedicated rooms within…
Endoscopic retrograde cholangiopancreatography (ERCP) has been a remarkable technological advance that has evolved over its nearly 50 years in the field of gastrointestinal endoscopy and has redefined the medical and surgical approach to patients with pancreatic and biliary tract diseases.…